Related news from
Mon, 15 Sep 2025 13:40:29 +0000	Cencora Stock: Is COR Outperforming the Health Care Sector? Cencora has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.
Fri, 12 Sep 2025 09:37:00 +0000	PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock? PACS Group, Inc. (PACS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Wed, 10 Sep 2025 13:45:03 +0000	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fri, 05 Sep 2025 12:06:00 +0000	Here's Why You Should Hold Cencora Stock in Your Portfolio Now COR gains from strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose risks.
Mon, 01 Sep 2025 13:40:02 +0000	Here's Why Cencora (COR) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Thu, 28 Aug 2025 17:21:19 +0000	Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board Cencora (COR) recently experienced a leadership transition with D. Mark Durcan set to become Chairman of the Board, which coincides with a 1.52% price move over the last month. The company's announcement of a $0.55 dividend and strong earnings results with increased sales and net income likely added weight to the positive market trends. While the broader market reached new highs, Cencora's movement aligns with these trends, reflecting the influence of both internal developments and broader...
Thu, 28 Aug 2025 15:40:01 +0000	COR vs. MEDP: Which Stock Is the Better Value Option? COR vs. MEDP: Which Stock Is the Better Value Option?
Thu, 28 Aug 2025 13:17:00 +0000	Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. GE, HWM, COR and CAKE are some such stocks.
Wed, 27 Aug 2025 20:15:00 +0000	Cencora Appoints Mark Durcan as Chairman of Its Board of Directors CONSHOHOCKEN, Pa., August 27, 2025--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has appointed Lead Independent Director D. Mark Durcan as Chairman of the Board of Directors, effective October 1, 2025. Mr. Durcan will succeed Steven H. Collis, who has served as Cencora’s Chairman since 2016 and previously served as Cencora’s Chief Executive Officer from 2011 until 2024. As previously disclosed, Mr. Collis was elected to serve as Executive Chairman of the Board effective
Wed, 27 Aug 2025 16:45:02 +0000	Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
Tue, 26 Aug 2025 13:50:02 +0000	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wed, 20 Aug 2025 13:40:03 +0000	Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year? Here is how Climb Bio, Inc. (CLYM) and Cencora (COR) have performed compared to their sector so far this year.
Tue, 19 Aug 2025 13:45:01 +0000	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mon, 18 Aug 2025 09:57:12 +0000	Cencora directors agree to $111M settlement over alleged opioid mismanagement The settlement brings to a close litigation from pension funds that argued Cencora’s leadership ignored red flags about improper opioid distribution practices for years in order to profit.
Fri, 15 Aug 2025 13:40:02 +0000	Why Cencora (COR) is a Top Value Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Thu, 14 Aug 2025 10:28:56 +0000	Cencora's (NYSE:COR) Earnings Seem To Be Promising NYSE:COR 1 Year Share Price vs Fair Value Explore Cencora's Fair Values from the Community and select yours Cencora...
Thu, 14 Aug 2025 03:34:11 +0000	Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Cencora (NYSE:COR) and the rest of the health insurance providers stocks fared in Q2.
Wed, 13 Aug 2025 13:44:30 +0000	Cencora Stock: Analyst Estimates & Ratings Cencora has outpaced the broader market over the past year, and Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.
Wed, 13 Aug 2025 05:34:39 +0000	The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call Cencora’s third quarter results outperformed Wall Street’s expectations on both revenue and adjusted profit, but the market reacted negatively, reflecting investor concerns about slower growth in key areas. Management attributed the quarter’s outcomes to continued strength in U.S. Healthcare Solutions, particularly specialty distribution and higher utilization of pharmaceuticals, including GLP-1 products. However, CEO Robert Mauch and CFO James Cleary acknowledged moderating growth in GLP-1s and
Tue, 12 Aug 2025 07:16:45 +0000	COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update Healthcare distributor Cencora (NYSE:COR) announced better-than-expected revenue in Q2 CY2025, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above analysts’ consensus estimates.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!